The chemistry of peroxovanadium compounds relevant to insulin mimesis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  1995-12-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01075913PMID 8927048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal Structure of 6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione

  2019cited by this paper
• Bisperoxovanadium compounds: synthesis and reactivity of some insulin mimetic complexes

  1995cited by this paper
• Hypoglycemic Effects of Peroxovanadium Compounds in Sprague-Dawley and Diabetic BB Rats

  1995cited by this paper
• Enzyme Interactions with Labile Oxovanadates and Other Polyoxometalates

  1994cited by this paper
• Crystal structure of human protein tyrosine phosphatase 1B.

  1994cited by this paper
• Potassium (5‐nitro‐1,10‐phenanthroline‐N1,N10)oxodiperoxovanadate(V) dihydrate: an insulin‐mimetic peroxovanadate

  1994cited by this paper
• A new orally active insulin-mimetic vanadyl complex: bis(pyrrolidine-N-carbodithioato)oxovanadium (IV).

  1994cited by this paper
• Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.

  1994cited by this paper
• Vanadium Peroxide Complexes

  1994cited by this paper
• Synthesis, spectrum and single crystal structure of a peroxovanadium complex of nitrilotriacetate ligand without water of crystallization, K2[VO(O2)NTA]

  1994cited by this paper
• Aqueous Chemistry of Labile Oxovanadates: Relevance to Biological Studies

  1994influential reference
• Ethylenediaminetetraacetato-monoperoxo complexes of vanadium(V)

  1994cited by this paper
• A FUNCTIONAL MODEL FOR VANADIUM HALOPEROXIDASE

  1994cited by this paper
• Insulin mimetic peroxovanadium complexes: preparation and structure of potassium oxodiperoxo(pyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(C5H4NCOO)].2H2O, and potassium oxodiperoxo(3-hydroxypyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(OHC5H3NCOO)].3H2O, and their reactions with cysteine

  1993cited by this paper
• Synthesis, characterization and crystal structure of barium (nitrilotriacetato) oxoperoxovanadate(V) trihydrate

  1993cited by this paper
• Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes.

  1992cited by this paper
• Synthesis and physico-chemical studies of newer mono and diperoxo heteroligand complexes of vanadium

  1992cited by this paper
• Bis(maltolato)oxovanadium(IV) is a potent insulin mimic.

  1992cited by this paper
• The Bioinorganic Chemistry of Vanadium

  1991cited by this paper
• Application of the Thianthrene 5‐Oxide Mechanistic Probe to Peroxometal Complexes.

  1991cited by this paper
• Formation and Decomposition of Peroxovanadium(V) Complexes in Aqueous Solution

  1991cited by this paper
• Unraveling the Chemistry of Tunichrome

  1991cited by this paper
• Synthesis, characterisation and physicochemical properties of peroxo-vanadium(V) complexes with glycine as the hetero-ligand

  1990cited by this paper
• Vanadium in Biological Systems

  1990cited by this paper
• Vanadates as Phosphate Analogs in Biochemistry

  1990cited by this paper
• Studies on transition metal peroxo complexes—X. The nature of peroxovanadates in aqueous solution

  1989cited by this paper
• Oxoperoxo(citrato)- and dioxo(citrato)vanadates(V): synthesis, spectra, and structure of a hydroxyl oxygen bridged dimer K2[VO(O2)(C6H6O7)]2.2H2O

  1989cited by this paper
• Reactivity of coordinated peroxide at a highly peroxygenated vanadium(V) center in an aqueous medium

  1989cited by this paper
• Oral vanadyl sulfate in treatment of diabetes mellitus in rats.

  1989cited by this paper
• Reactivation of vanadate-inhibited enzymes with desferrioxamine B, a vanadium(V) chelator

  1989cited by this paper
• Preparation, spectroscopic properties, and characterization of novel peroxo complexes of vanadium(V) and molybdenum(VI) with nicotinic acid and nicotinic acid N-oxide

  1988cited by this paper
• The tunichromes. A class of reducing blood pigments from sea squirts: isolation, structures, and vanadium chemistry.

  1988cited by this paper
• Vanadium-51 shielding in vanadium(V) complexes: a reference scale for vanadium binding sites in biomolecules

  1988cited by this paper
• Vanadium — an element involved in the biosynthesis of halogenated compounds and nitrogen fixation

  1987cited by this paper
• 51V NMR Investigation of a Vanadate(V)-dependent Peroxidase From Ascophyllum nodosum (L.) Le Jol.

  1987cited by this paper
• 51V NMR Investigation of a vanadate(V)-dependent peroxidase from ascophyllum nodosum (L.) Le Jol

  1987cited by this paper
• The bromoperoxidase from the red alga Ceramium rubrum also contains vanadium as a prosthetic group

  1987cited by this paper
• The bromoperoxidase from the lichen Xanthoria parietina is a novel vanadium enzyme.

  1987cited by this paper
• Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase.

  1987cited by this paper
• The crystal structures of potassium bis(oxalato) oxoperoxovanadate (V) hemihydrate, K3[VO(O2)(C2O4)2]•1/2H2O, and potassium bis(oxalato) dioxovanadate (V) trihydrate, K3[VO2(C2O4)2]•3H2O

  1986cited by this paper
• The alternative nitrogenase of Azotobacter chroococcum is a vanadium enzyme

  1986cited by this paper
• Role of vanadium in biology. Symposium summary.

  1986cited by this paper
• Notes. First synthesis and structural assessment of alkali-metal carbonatodioxoperoxouranate(VI) monohydrates, A2[UO2(O2)(CO3)]·H2O, and carbonato-oxodiperoxovanadate(V) trihydrates, A3[VO(O2)2(CO3)]·3H2O

  1986cited by this paper
• Isolation of a new vanadium-containing nitrogenase from Azotobacter vinelandii.

  1986cited by this paper
• A polymeric peroxo heteroligand vanadate(V). Synthesis, spectra, and structure of MI[VO(O2)(C4H5O4N)]

  1985cited by this paper
• Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium.

  1985cited by this paper
• X-ray structure of the [HV2O11]3− ion in the ammonium salt (NH4)3[HO{VO(O2)2}2] · H2O

  1985cited by this paper
• The Crystal Structure of Potassium Carbonatooxodiperoxovanadate(V), K3[VO(O2)2(CO3)].

  1985cited by this paper
• Crystal Structure of Potassium Carbonato-oxodiperoxovanadate(V), K3(VO(O2)2(CO3)).

  1985cited by this paper
• Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

  1985cited by this paper
• First synthesis and structural assessment of alkali-metal triperoxovanadates(V), A[V(O2)3]

  1985cited by this paper
• The [VO(O 2 ) 2 Cl] 2- -[V(O 2 ) 3 Cl] 2- pair in peroxyvanadium(V) chemistry: synthesis of the first chloroperoxyvanadate(V) compounds and evidence for diperoxyvanadate(V)-triperoxyvanadate(V) interconversion

  1984cited by this paper
• Peroxidases from phaeophyceae: A vanadium(V)-dependent peroxidase from Ascophyllum nodosum

  1984cited by this paper
• The Crystal Structure of 2,2'-Bipyridinium(1+) (2,2'-Bipyridine)oxodiperoxovanadate(1-)-(3+x)-hydrogen peroxide-(2-x)-water, (C10H9N2)[VO(O2)2(C10H8N2)].(3+x)H2O2.(2-x)H2O, x = 0.4, at -100 degrees C.

  1984cited by this paper
• The Crystal Structure of Ammonium mu-Oxo-bis(oxodiperoxovanadate)(4--), (NH4)4[O{VO(O2)2}2]. A Refinement.

  1984cited by this paper
• The crystal structure of ammonium difluorooxodiperoxovanadate(V), (NH4)3 [VF2O(O2)2]

  1984cited by this paper
• The crystal structure of potassium fluorooxodiperoxovanadate (V), K2 [VFO(O2)2]

  1984cited by this paper
• The Crystal Structure of 2,2'-Bipyridinium(1+) mu-Hydrogen-bis[(2,2'-bipyridine)oxodiperoxovanadate](1-)-x-hydrogen peroxide-(6-x)-water, (Hbipy)[H{VO(O2)2bipy}2].xH2O2.(6-x)H2O, x ~= 0.5, at -100 degrees C.

  1984cited by this paper
• On the existence of triperoxo vanadium complexes. X-ray crystal structures of K3[VO(O2)2(C2O4]· H2O2 and of (NH4)[VO(O2)2(bipy)·4H2O

  1983cited by this paper
• The Crystal Structure of Ammonium (2,2'-Bipyridine)oxodiperoxovanadate(V) Tetrahydrate, NH4[VO(O2)2(C10H8N2)].4H2O, at -100 degrees C.

  1983cited by this paper
• Vanadium(V) peroxy complexes. New versatile biomimetic reagents for epoxidation of olefins and hydroxylation of alkanes and aromatic hydrocarbons

  1983cited by this paper
• The Crystal Structure of (2,2'-Bipyridine)oxoperoxo(pyridine-2-carboxylato)vanadium(V) Hydrate, [VO(O2)(C5H4NCOO)(C10H8N2)].H2O at -100 degrees C.

  1983cited by this paper
• Vibrational spectra of ammonium ammine-oxo-diperoxovanadate

  1982cited by this paper
• Synthesis of alkali oxydiperoxyfluorovanadates(V)

  1982cited by this paper
• ALKALI-METAL AND AMMONIUM TRIPEROXYFLUOROVANADATES(V), A2(V(O2)3F)

  1982cited by this paper
• Vanadyl(IV) EPR Spin Probes Inorganic and Biochemical Aspects

  1981cited by this paper
• The 51V NMR Spectra of Some Oxo-, Peroxo-, Nitrosyl- and Hydroxylamidovanadium Complexes

  1981cited by this paper
• The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor.

  1980cited by this paper
• Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions

  1980cited by this paper
• Oxo-peroxokomplexe des Vanadiums(V)

  1980cited by this paper
• Insulin-mimetic effects of vanadate in isolated rat adipocytes

  1980cited by this paper
• KINETICS OF THE DIPEROXOVANADATE(V)-MONOPEROXOVANADATE(V) CONVERSION IN PERCHLORIC ACID MEDIA

  1979cited by this paper
• Effects of vanadium on glucose metabolism in vitro.

  1979cited by this paper
• PREPARATION AND CHARACTERIZATION OF DIPICOLINATOVANADIUM(V) COMPLEXES. KINETICS AND MECHANISM OF THEIR REACTION WITH HYDROGEN PEROXIDE IN ACIDIC MEDIA

  1978cited by this paper
• Electronic spectra of metal-dioxygen complexes

  1978cited by this paper
• AN ASYMMETRICALLY COORDINATED DIPEROXO COMPOUND CRYSTAL STRUCTURE OF K3(VO(O2)2(C2O4)).H2O

  1975cited by this paper
• Asymmetrically coordinated diperoxo compound. Crystal structure of tripotassium oxodiperoxooxalatovanadate(V) monohydrate

  1975cited by this paper
• Oxodiperoxovanadate(V) complexes with bidentate ligands

  1973cited by this paper
• Crystal structure at -100.deg. of ammonium oxoperoxo(pyridine-2,6-dicarboxylato)vanadate(V) hydrate, NH4[VO(O2)(H2O)(C5H3N(COO)2)].xH2O (x .aeq. 1.3)

  1973cited by this paper
• Crystal structure of ammonium oxodiperoxoamminevanadate(V)

  1972cited by this paper
• Peroxo-complexes: triperoxovanadates(V) complexes

  1971cited by this paper
• Darstellung von Ammonium‐[(pyridin‐2.6‐dicarboxylato)‐oxo‐peroxoaquo‐vanadat(V)]

  1959cited by this paper
• ‘Comprehensive’ Inorganic Chemistry

  1958cited by this paper

• Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects

  2021cites this paper
• Experimental and molecular topology-based biological implications of Schiff base complexes: a concise review

  2019cites this paper
• Oxidative stress changes observed in selected organs of African giant rats (Cricetomys gambianus) exposed to sodium metavanadate

  2018cites this paper
• Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome

  2017cites this paper
• Niobium(V) peroxo α-amino acid complexes: Synthesis, stability and kinetics of inhibition of acid phosphatase activity

  2017cites this paper
• Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities

  2017cites this paper
• A Doubly Biomimetic Synthetic Transformation: Catalytic Decarbonylation and Halogenation at Room Temperature by Vanadium Pentoxide

  2016cites this paper
• Macromolecular peroxo complexes of Vanadium(V) and Molybdenum(VI): Catalytic activities and biochemical relevance

  2015cites this paper
• The chemistry and biology of vanadium compounds in cancer therapeutics

  2015cites this paper
• Roles of Igh Intronic Enhancer Eμ in Clonal Selection at the Pre-B to Immature B Cell Transition and in the Elimination of Autoreactive B Cells

  2014cites this paper
• Identification and characterization of novel drugs for the treatment of pediatric gliomas

  2014cites this paper
• DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands.

  2013cites this paper
• 3.13 – Vanadium Biochemistry

  2013cites this paper
• Regulation of the physiological effects of peroxidovanadium(V) complexes by the electronic nature of ligands.

  2013cites this paper
• Preclinical evaluation of dipotassium bisperoxo (picolinato) oxovanadate V for the treatment of pediatric low-grade gliomas.

  2013cites this paper
• Effect of peroxides on spermine transport in rat brain and liver mitochondria

  2012influential citation
• Vanadium, Niobium, and Tantalum

  2012cites this paper
• Implications of oxidovanadium(IV) binding to actin.

  2011cites this paper
• Analysis of metals in commercial samples of erva-mate from South of Brazil.

  2010cites this paper
• The structure, stability, and reactivity of oxalato-monoperoxovanadium(V) in solution

  2010cites this paper
• Speciation in aqueous vanadate-ligand and peroxovanadate-ligand systems.

  2009cites this paper
• Role of the alkali metal ion and hydrogen bonds in M[VO(O2)2bpy] · nH2O (M = Li+, Na+, K+ and Rb+) and Cs[VO(O2)2bpy] · H2O2 complexes: The X-ray crystal structures and spectroscopic properties

  2009cites this paper
• Mononuclear and dinuclear peroxotungsten complexes with co-ordinated dipeptides as potent inhibitors of alkaline phosphatase activity.

  2008cites this paper
• New peroxovanadium compounds containing biogenic co-ligands: synthesis, stability and effect on alkaline phosphatase activity

  2008cites this paper
• Mononuclear and dinuclear peroxotungsten complexes with co-ordinated dipeptides as potent inhibitors of alkaline phosphatase activity

  2008cites this paper
• Efeito do sulfato de vanadil sobre o comprometimento metabólico muscular induzido pela imobilização de membro posterior de ratos

  2006cites this paper
• Effect of the vanadyl sulphate on the muscular metabolic compromising induced by immobilization of posterior limb of rats

  2006cites this paper
• New oxo-bridged peroxotungsten complexes containing biogenic co-ligand as potent inhibitors of alkaline phosphatase activity

  2006cites this paper
• Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors.

  2006cites this paper
• Redox modulation of basal and β‐adrenergically stimulated cardiac L‐type Ca2+ channel activity by phenylarsine oxide

  2004cites this paper
• Synthesis of new dinuclear and mononuclear peroxovanadium(V) complexes containing biogenic co-ligands: a comparative study of some of their properties

  2004cites this paper
• Peroxovanadium compounds as inhibitors of angiogenesis

  2004cites this paper
• Speciation in the aqueous H+/H2VO4-/H2O2/citrate system of biomedical interest.

  2004cites this paper
• REDUÇÃO DA GLICEMIA EM RATOS DIABÉTICOS TRATADOS COM SAIS DE VANÁDIO PEROXIDADOS

  2004cites this paper
• Kinetics and mechanistic studies of anticarcinogenic bisperoxovanadium(V) compounds: ligand substitution reactions at physiological pH and relevance to DNA interactions.

  2003cites this paper
• Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.

  2003cites this paper
• Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  2003cites this paper
• Positive and negative selection during B lymphocyte development

  2003cites this paper
• Peroxovanadate inhibits Ca2+ release from mitochondria

  2002cites this paper
• Coordinated action of protein tyrosine phosphatases in insulin signal transduction.

  2002cites this paper
• Bisperoxovanadium complex promotes dopamine exocytosis in PC12 cells.

  2002cites this paper
• Immobilized liposome layers for drug delivery applications: inhibition of angiogenesis.

  2002cites this paper
• Reaction of diperoxovanadate with vanadyl sulphate in presence of EDTA as an access to dinuclear peroxovanadates(V)

  2002cites this paper
• Syntheses, structures, stability, and insulin-like activities of peroxovanadium(V) complexes with a heteroligand.

  2001cites this paper
• Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)*

  2001cites this paper
• Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.

  2001cites this paper
• Properties of small molecules affecting insulin receptor function.

  2001cites this paper
• MKP-1 as a target for pharmacological manipulations in PC12 cell survival.

  2001cites this paper
• pH-dependent investigations of vanadium(V)-peroxo-malate complexes from aqueous solutions. In search of biologically relevant vanadium(V)-peroxo species.

  2001cites this paper
• Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis

  2001cites this paper
• Tyrosine phosphatase inhibitors selectively antagonize beta-adrenergic receptor-dependent regulation of cardiac ion channels.

  2000cites this paper
• Insulin mimesis of vanadium derivatives. Oxidation of cysteine by V(V) oxo diperoxo complexes.

  2000cites this paper
• Modulation of insulin signaling by protein tyrosine phosphatases

  2000cites this paper
• Identification of a unique liganded estrogen receptor complex released from the nucleus by decavanadate.

  1999cites this paper
• Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.

  1999cites this paper
• Pharmacological applications of inorganic complexes.

  1999cites this paper
• Periodinates: a new class of protein tyrosine phosphatase inhibitors.

  1999cites this paper
• From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling.

  1998cites this paper
• Multifunctional actions of vanadium compounds on insulin signaling pathways: Evidence for preferential enhancement of metabolic versus mitogenic effects

  1998cites this paper
• Vanadium compounds biological actions and potential as pharmacological agents.

  1997cites this paper
• Therapeutic peptides and peptidomimetics.

  1997cites this paper
• Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research.

  1996cites this paper
• Cleavage of DNA by the insulin-mimetic compound, NH4[VO(O2)2(phen)].

  1996cites this paper